We studied changes in the atherogenic index (total cholesterol divided by high-density lipoprotein cholesterol) in 12 prepubertal boys with growth hormone (GH) deficiency during 9 months of GH treatment. High-density lipoprotein cholesterol level increased until 5 months without significant changes in total cholesterol level; thus GH therapy may be beneficial in reducing the atherogenic index in boys with GH deficiency.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0022-3476(95)70220-2 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!